DOCSLIB.ORG

Official Journal of the European Union C 76/1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Official Journal of the European Union C 76/1 Official Journal C 76 of the European Union Volume 59 English edition Information and Notices 26 February 2016 Contents IV Notices NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES European Commission 2016/C 076/01 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 January 2016 to 31 January 2016 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council) . 1 2016/C 076/02 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 January 2016 to 31 January 2016 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC) . 10 EN 26.2.2016 EN Official Journal of the European Union C 76/1 IV (Notices) NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 January 2016 to 31 January 2016 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1)) (2016/C 076/01) (1) OJ L 136, 30.4.2004, p. 1. C 76/2 — Issuing of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted EN INN (International Number of the entry in ATC code (Anatomi- Date of the Name of the medicinal Date of noti- Non-Proprietary Holder of the marketing authorisation the Community Regis- Pharmaceutical form cal Therapeutic Che- decision product fication Name) ter mical Code) 11.1.2016 Eptifibatide Accord eptifibatide Accord Healthcare Limited EU/1/15/1065 Solution for infusion B01AC16 13.1.2016 Sage House, 319 Pinner Road, North Harrow, Mid- Solution for injec- dlesex, HA1 4HF, United Kingdom tion 14.1.2016 Benepali etanercept Samsung Bioepis UK Limited EU/1/15/1074 Solution for injec- L04AB01 18.1.2016 Off 3000 Hillswood Drive, Chertsey, Surrey KT16 0RS, tion icial United Kingdom Jour nal 14.1.2016 Briviact brivaracetam UCB Pharma S.A. EU/1/15/1073 Film-coated tablet N03AX23 18.1.2016 Allée de la Recherche 60, 1070 Bruxelles, Belgique/ Oral solution of Researchdreef 60, 1070 Brussel, België Solution for injec- the tion or infusion European 14.1.2016 Episalvan birch bark ex- Birken AG EU/1/15/1069 Gel Pending 18.1.2016 tract Streiflingsweg 11, D-75223 Niefern-Öschelbronn, Uni Deutschland on 14.1.2016 Lopinavir/Ritonavir lopinavir/ritona- Mylan S.A.S EU/1/15/1067 Film-coated tablet J05AR10 18.1.2016 Mylan vir 117 allée des Parcs, F-69800 Saint Priest, France 14.1.2016 Oncaspar pegaspargase Baxalta Innovations GmbH EU/1/15/1070 Powder and solvent L01XX24 18.1.2016 Industriestrasse 67, A-1221 Vienna, Österreich for solution for in- jection/infusion 14.1.2016 Spectrila asparaginase medac Gesellschaft für klinische Spezialpräparate mbH EU/1/15/1072 Powder for concen- L01XX02 18.1.2016 Theaterstr. 6, D-22880 Wedel, Deutschland trate for solution for infusion 26.2.2016 26.2.2016 INN (International Number of the entry in ATC code (Anatomi- Date of the Name of the medicinal Date of noti- Non-Proprietary Holder of the marketing authorisation the Community Regis- Pharmaceutical form cal Therapeutic Che- decision product fication Name) ter mical Code) 18.1.2016 Pemetrexed Accord pemetrexed Accord Healthcare Limited EU/1/15/1071 Powder for concen- L01BA04 20.1.2016 EN Sage House, 319 Pinner Road, North Harrow, Mid- trate for solution for dlesex, HA1 4HF, United Kingdom infusion 18.1.2016 Pemetrexed Actavis pemetrexed Actavis Group PTC ehf. EU/1/15/1063 Concentrate for so- L01BA04 21.1.2016 Reykjavíkurvegur 76-78, 220 Hafnarfjörður, Ísland lution for infusion Off icial Jour nal of the European Uni on C 76/3 C 76/4 EN Official Journal of the European Union 26.2.2016 — Modification of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted Date of the Name of the medic- Number of the entry in Date of noti- Holder of the marketing authorisation decision inal product the Community Register fication 7.1.2016 Bosulif Pfizer Limited EU/1/13/818 11.1.2016 Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom 7.1.2016 Kuvan BioMarin International Limited EU/1/08/481 11.1.2016 Shanbally, Ringaskiddy, County Cork, Ireland 7.1.2016 Sildenafil Teva Teva B.V. EU/1/09/584 11.1.2016 Swensweg 5, 2031 GA Haarlem, Nederland 7.1.2016 Sirturo Janssen-Cilag International NV EU/1/13/901 11.1.2016 Turnhoutseweg 30, B-2340 Beerse, België 11.1.2016 Cometriq TMC Pharma Services Ltd EU/1/13/890 13.1.2016 Lodge Farm Barn, Elvetham Park Estate, Fleet Road, Hartley Wintney, Hampshire RG27 8AS, United Kingdom 11.1.2016 Latuda Takeda Pharma A/S EU/1/14/913 13.1.2016 Dybendal Alle 10, 2630 Taastrup, Danmark 11.1.2016 Sivextro Merck Sharp & Dohme Limited EU/1/15/991 13.1.2016 Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom 11.1.2016 Yellox PharmaSwiss Česká republika s.r.o. EU/1/11/692 13.1.2016 Jankovcova 1569/2c 17000 Praha 7 Česká republika 11.1.2016 Zinforo AstraZeneca AB EU/1/12/785 13.1.2016 SE-151 85 Södertälje, Sverige 12.1.2016 Atriance Novartis Europharm Limited EU/1/07/403 14.1.2016 Frimley Business Park, Camberley GU16 7SR, United Kingdom 12.1.2016 Cervarix GlaxoSmithKline Biologicals S.A. EU/1/07/419 14.1.2016 rue de l’Institut 89, 1330 Rixensart, Belgique 12.1.2016 Gardasil Sanofi Pasteur MSD SNC EU/1/06/357 14.1.2016 162 avenue Jean Jaurès, 69007 Lyon, France 12.1.2016 Gardasil 9 Sanofi Pasteur MSD SNC EU/1/15/1007 14.1.2016 162 avenue Jean Jaurès, 69007 Lyon, France 12.1.2016 Silgard Merck Sharp & Dohme Limited EU/1/06/358 14.1.2016 Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom 14.1.2016 Bronchitol Pharmaxis Pharmaceuticals Limited EU/1/12/760 18.1.2016 25 Moorgate, London, EC2R 6AY, United King- dom. 14.1.2016 Caprelsa AstraZeneca AB EU/1/11/749 18.1.2016 SE-151 85 Södertälje, Sverige 26.2.2016 EN Official Journal of the European Union C 76/5 Date of the Name of the medic- Number of the entry in Date of noti- Holder of the marketing authorisation decision inal product the Community Register fication 14.1.2016 Eliquis Bristol-Myers Squibb/Pfizer EEIG EU/1/11/691 18.1.2016 Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex UB8 1DH, United Kingdom 14.1.2016 Evoltra Genzyme Europe B.V. EU/1/06/334 18.1.2016 Gooimeer 10, NL-1411 DD Naarden, Nederland 14.1.2016 Glivec Novartis Europharm Limited EU/1/01/198 18.1.2016 Frimley Business Park, Camberley GU16 7SR, United Kingdom 14.1.2016 Leganto UCB Manufacturing Ireland Ltd EU/1/11/695 19.1.2016 Shannon Industrial Estate, Co, Clare, Ireland 14.1.2016 Lumigan Allergan Pharmaceuticals Ireland EU/1/02/205 18.1.2016 Castlebar Road, Westport, County Mayo, Ireland 14.1.2016 Pravafenix LABORATOIRES SMB SA EU/1/11/679 18.1.2016 26-28 rue de la Pastorale/26-28 Herderslied- straat, 1080 Brussel/Bruxelles, Belgique/België 14.1.2016 Rotarix GlaxoSmithKline Biologicals S.A. EU/1/05/330 18.1.2016 rue de l’Institut 89, 1330 Rixensart, Belgique 14.1.2016 Torisel Pfizer Limited EU/1/07/424 18.1.2016 Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom 14.1.2016 Trobalt Glaxo Group Ltd EU/1/11/681 18.1.2016 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom 14.1.2016 VELCADE Janssen-Cilag International NV EU/1/04/274 18.1.2016 Turnhoutseweg 30, B-2340 Beerse, België 14.1.2016 Xeloda Roche Registration Limited EU/1/00/163 18.1.2016 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom 18.1.2016 Repso Teva B.V. EU/1/11/674 20.1.2016 Swensweg 5, 2031 GA Haarlem, Nederland 18.1.2016 Xagrid Shire Pharmaceutical Contracts Ltd EU/1/04/295 20.1.2016 Hampshire International Business Park, Chine- ham, Basingstoke, Hampshire RG24 8EP, United Kingdom 18.1.2016 Xiapex Swedish Orphan Biovitrum AB (publ) EU/1/11/671 20.1.2016 SE-112 76 Stockholm, Sverige 22.1.2016 Clopidogrel Teva Teva B.V. EU/1/09/561 26.1.2016 Pharma Swensweg 5, 2031 GA Haarlem, Nederland C 76/6 EN Official Journal of the European Union 26.2.2016 Date of the Name of the medic- Number of the entry in Date of noti- Holder of the marketing authorisation decision inal product the Community Register fication 22.1.2016 Kadcyla Roche Registration Limited EU/1/13/885 26.1.2016 6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom 22.1.2016 Levitra Bayer Pharma AG EU/1/03/248 26.1.2016 D-13342 Berlin, Deutschland 22.1.2016 Levodopa/Carbido- Orion Corporation EU/1/11/706 26.1.2016 pa/Entacapone Or- Orionintie 1, FI-02200 Espoo, Suomi ion 22.1.2016 Neupro UCB Manufacturing Ireland Ltd EU/1/05/331 26.1.2016 Shannon Industrial Estate, Co, Clare, Ireland 22.1.2016 Nplate Amgen Europe B.V. EU/1/08/497 26.1.2016 Minervum 7061, NL-4817 ZK Breda, Nederland 22.1.2016 Ofev Boehringer Ingelheim International GmbH EU/1/14/979 26.1.2016 Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland 22.1.2016 Optaflu Novartis Influenza Vaccines Marburg GmbH EU/1/07/394 26.1.2016 Emil-von-Behring-Straße 76, D-35041 Marburg, Deutschland 22.1.2016 Topotecan Actavis Actavis Group PTC ehf.
Load more

Recommended publications
  • Žiadosť O Zmenu Integrovaného Povolenia Prevádzky Podľa Zákona O Integrovanej Prevencii a Kontrole Znečisťovania Životného Prostredia V Zmysle Zákona Č
    Liaharenský podnik Nitra a.s. 94901 Nitra – Párovské Háje Žiadosť o zmenu integrovaného povolenia prevádzky podľa zákona o Integrovanej prevencii a kontrole znečisťovania životného prostredia v zmysle zákona č. 39/2013 Máj 2020 1 Obsah: A Údaje identifikujúce prevádzkovateľa 1 Základné informácie 2 Informácie o povoľovanej prevádzke 3 Ďalšie informácie o prevádzke 4 Základné informácie o stavebných objektoch prevádzky 5 Informácie k žiadosti o zmenu vydaného integrovaného povolenia 6 Utajované a dôverné údaje B Údaje o prevádzke a jej umiestnení 1 Všeobecná charakteristika prevádzky z hľadiska technického, výroby a služieb 2 Mapový list lokalizujúci umiestnenie povoľovanej prevádzky v rámci celého závodu 3 Opis prevádzky 4 Bloková schéma a materiálová bilancia prevádzky v členení na jednotlivé technologické uzly 5 Dokumentácia k prevádzkovaniu prevádzky C Zoznam surovín, pomocných materiálov a ďalších látok a energií, ktoré sa v prevádzke používajú alebo vyrábajú 1 Suroviny, pomocné materiály a ďalšie látky, ktoré sa v prevádzke používajú 1.1 Zoznam surovín, pomocných materiálov a ďalších látok 1.2 Voda používaná na výrobné a prevádzkové účely 1.3 Voda používaná na pitné a sociálne účely 2 Výrobky a medziprodukty, ktoré sa v prevádzke vyrábajú 2.1 Výrobky alebo skupiny určených výrobkov 2.2 Medziprodukty 3 Energie v prevádzke používané alebo vyrábané 3.1 Vstupy energie a palív 3.2 Vlastná výroba energií z palív 3.3 Opis všetkých spotrebičov energií 3.4 Využitie energií 3.5 Merná spotreba energie D Opis miest prevádzky, v ktorých vznikajú emisie a údaje o predpokladaných množstvách a druhoch emisií do jednotlivých zložiek životného prostredia spolu s opisom významných účinkov emisií a ďalších vplyvov na životné prostredie a na zdravie ľudí 1 Znečisťovanie ovzdušia 1.1 Zoznam zdrojov a emisií do ovzdušia vrátane zapáchajúcich látok a spôsob zachytávania emisií 1.2 Zoznam miest vypúšťania emisií do ovzdušia pre jednotlivé zdroje emisií 2 Znečisťovanie povrchových vôd 2.1 Recipienty odpadových vôd 2.2.
    [Show full text]
  • Download Module I
    multifunctional Farming for the sustainability of European Agricultural Landscapes Project Nº: 2016- 1- SK01- KA202- 022502 NAČELA MULTIFUNKCIJSKEGA KMETIJSTVA IN EAL Kmetijska krajina – priložnost za diverzifikacijo dejavnosti na kmetiji NAČELA MULTIFUNKCIJSKEGA KMETIJSTVA IN EAL Opis modula Pregled: Ta modul pojasnjuje, kako bi lahko znanje o krajinskih vrednotah evropskih kmetijskih krajin (EAL) odprlo nova obzorja za vzpostavitev kmetij, ki opravljajo različne nekmetijske dejavnosti in s tem uresničujejo večfunkcijsko kmetijstvo. Ozaveščenost kmetovalcev in ostalih deležnikov o vrednotah kmetijske krajine pripomore k spopadanju z izzivi Evropske konvencije o krajini (CoE, 2000). • Učni cilji Znanje Razumevanje tipologije EAL in njihovih atributov , ki privedejo do multifunkcionalnosti EAL. Know-how za uporabo multifunkcijskih dejavnosti znotraj različnih EAL. Skills Prepoznavanje krajinskih tipov– EAL in vrednot različnih EAL in njihovih krajinskih značilnosti . Prakticiranje multifunkcijskega kmetijstva v povezavi z značilnostmi določene EAL. Zagotavljanje ustreznega vzdrževanja EAL, ohranjanje vednot EAL in izboljšava njihove kakovosti. Odnos Ozaveščenost za izboljšanje kakovosti in vzdrževanja EAL na trajnostni način z ohranjanjem krajinskih značilnosti. Moduli za usposabljanje so povezani z Zbirnim poročilom - Študijskimi primeri - E-atlas. NAČELA MULTIFUNKCIJSKEGA KMETIJSTVA IN EAL Index • Mednarodni kntekst EAL predstavljen v študijskih primerih • EAL predstavljene v študijskih primerih • Nacionalni kontekst EAL predstavljenih
    [Show full text]
  • Current Registered Companies 7Th EPLS, Prague July 2014 Company
    Current Registered Companies 7th EPLS, Prague July 2014 Company Name Country AbbVie Deutschland GmbH & Co. KG Germany Abiogen Pharma SpA Italy Acraf S.p.A. Italy Actavis UK Ltd UK Adamed Labs (Spain) Spain Alkaloidpharm SA Switzerland Alliance Pharmaceuticals Limited UK Almirall S.A. Spain Alsevia Pharma France Amdipharm Mercury Ltd UK Apogepha Arzneimittel GmbH Germany Aptalis Pharma Italy Archimedes Pharma UK Aspire Pharma Ltd UK AstraZenca GmbH Germany Atnahs UK Holdings Limited UK Bayer Pharma AG Germany Bayer Vital GmbH Germany Berlin-Chemie AG Germany Besins Healthcare (UK) Ltd UK Biocodex France Boehringer Ingelheim Pharma GmbH & Co. KG Germany China Medical Systems Holdings UK Contrad Swiss SA Switzerland Creo Pharma Ltd UK Csendes Consulting Switzerland Desitin Arzneimittel GmbH Germany Desma Healthcare Switzerland Dr Kade Pharma Germany Dr M. Newzella GmbH Germany Egamid Ltd UK Esteve Spain EVER Neuro Pharma GmbH Austria Faes Farma, S.A. Spain Fasken Martineau LLP UK Fine Foods & Pharmaceuticals NTM SpA Italy Geistlich Pharma Switzerland Genericon Pharma GmbH Austria Glenmark Pharmaceuticals Ltd UK Helsinn Healthcare SA Switzerland Hermes Arzneimittel GmbH Germany Hetero Europe S.L. Spain Hyperion Corporate Development Ltd UK IMI Consultanting Germany Intrapharm Laboratories Ltd UK Janssen The Netherlands Janssen Spain Janssen Pharmaceutica NV Belgium Janssen-Cilag s.r.o. Czech Republic Current Registered Companies 7th EPLS, Prague July 2014 Koi Consulting Partners UK Kyorin Europe Germany Laboratorios Rubió, S.A. Spain LTS Lohmann Therapie-Systeme AG Germany Lupin Atlantis Holdings SA Switzerland Medinova AG Switzerland Merck KGaA Germany Mike Parnell Consultant UK MorphoSys AG Germany Nordic Pharma Ltd UK Nordic Pharma, s.r.o.
    [Show full text]
  • Estado De São Paulo
    ESTADO DE SÃO PAULO COMUNICADO DEAT - Série Nota Fiscal Eletrônica Nº. 104/2008 ATO DE CREDENCIAMENTO E OBRIGATORIEDADE DE EMISSÃO DE NF-E O Diretor Executivo da Administração Tributária, tendo em vista o disposto no Ajuste SINIEF 07/05, de 30 de setembro de 2005, no Protocolo ICMS 10/07, de 18 de abril de 2.007, na alínea “d” do item 5 do § 3º do artigo 212-O do Regulamento do Imposto sobre Operações Relativas à Circulação de Mercadorias e sobre Prestações de Serviços de Transporte Interestadual e Intermunicipal e de Comunicação, aprovado pelo Decreto n° 45.490, de 30 de novembro de 2000, e no item 2 do parágrafo 1º do artigo 2º da Portaria CAT 104, de 14/11/2007, comunica a todos os interessados que: 1 – Ficam credenciados pela Secretaria da Fazenda, para emitir Nota Fiscal Eletrônica, Modelo 55, em substituição à Nota Fiscal Modelo 1 ou 1-A, a partir de 1º de dezembro de 2.008, os estabelecimentos constantes no Anexo Único; 2 – Os estabelecimentos dos contribuintes ora credenciadas deverão, em virtude de suas atividades econômicas e, nos termos do Artigo 21 da Portaria CAT 104, de 14/11/2007, utilizar Nota Fiscal Eletrônica – NF-e, modelo 55, para acobertar todas as suas operações, sendo vedada a emissão de Nota Fiscal, modelo 1 ou 1-A; 3 – O contribuinte, relativamente aos estabelecimentos de que trata o item 1: a) poderá efetuar testes de suas aplicações no ambiente eletrônico de homologação da Secretaria da Fazenda, nos endereços informados na página da Nota Fiscal Eletrônica www.fazenda.sp.gov.br/nfe ; b) deverá, até prazo de que
    [Show full text]
  • Funcionamento Das Farmácias E Drogarias Do Município De Anchieta-ES PORTARIA Nº 040, De 22 De Setembro De 2020
    Prefeitura de Anchieta SECRETARIA MUNICIPAL DE SAÚDE - FMS CNPJ Nº 14.051.123/0001-66 Portaria de funcionamento das farmácias e drogarias do Município de Anchieta-ES PORTARIA nº 040, de 22 de setembro de 2020. “Estabelece a escala para funcionamento noturno e aos domingos e feriados das farmácias e drogarias do município de Anchieta-ES e da outras providências.” A Secretária de Saúde do Município de Anchieta, Estado do Espírito Santo, no uso de suas atribuições que lhe são conferidas e: Considerando a regra prevista no § 2º do art. 194 do Código de Posturas; Considerando o teor do Decreto nº 3.284/2010; Lei Municipal nº 931, DE 19 de maio de 2014, que dispõe sobre o funcionamento das farmácias e drogarias do município de Anchieta/ES. Considerando a regra prevista no parágrafo único no art. 71 da LOM. Resolve: Art. 1º Estabelecer escala dos termos do Art. 2º § 1º do Decreto Municipal nº 3.284/2010 para funcionamento de farmácias e drogarias, para o período de 16 de outubro de 2020 a 15 de abril de 2021, conforme anexo único. Art. 2º Poderá haver permuta na escala entre as empresas citadas no artigo anterior desta Portaria, desde que previamente divulgada e comunicada, via ofício, à Secretaria de Saúde do Município de Anchieta-ES. Art. 3º Nos dias e horários previstos no Art. 2º do Decreto Municipal nº 3.284/2010, as farmácias e drogarias que estiverem fechadas ficam obrigadas a afixar na parte externa do estabelecimento, em local visível ao público, escala com indicação clara e precisa do estabelecimento que está em plantão após as 22h, de segunda a sábado e aos domingos e feriados.
    [Show full text]
  • Codigo Nombre Via Direccion Nº Resto
    CODIGO NOMBRE VIA DIRECCION Nº RESTO DIRECCION LOCALIDAD PROVINCIA CP TELEFONO PAIS 1 ABBOTT LABORATORIES AVDA DE BURGOS 91 MADRID MADRID 28050 901200102 ESPAÑA 2 ABELLO JOSEFA VALCARCEL 38 MADRID MADRID 28027 ESPAÑA 5 BARNATRON AVD JOSEP ANSELM CLAVE 100 ESPLUGUES DE LLOBREGAT BARCELONA 8950 934735144 ESPAÑA 11 ALDO UNION BARONESA DE MALDA, 73 ESPLUGAS DE LLOBREGAT BARCELONA 8950 933727111 ESPAÑA 13 CENTRO ANDALUZ DE DIAGNOSTICO PET RD CAPUCHINOS 11 SEVILLA SEVILLA 41009 ESPAÑA 14 ALMIRALL S.A. RDA. GRAL. MITRE 151 BARCELONA BARCELONA 8022 ESPAÑA 15 ALTER MATEO INURRIA, 30 MADRID MADRID 28036 913592000 ESPAÑA 18 GRÜNENTHAL PHARMA DR. ZAMENHOF 36 MADRID MADRID 28027 913019300 ESPAÑA 22 LABORATORIOS DIAFARM AVDA D'ARRAONA 119 BARBERA DEL VALLES BARCELONA 8210 937192120 ESPAÑA 34 ANGELINI FARMACÉUTICA S.A. C/ OSI 7 BARCELONA BARCELONA 8034 932534505 ESPAÑA 64 BRUM QUEVEDO 4 OVIEDO ASTURIAS 33012 985297111 ESPAÑA 70 BOEHRINGER INGELHEIM, S.A. C PRAT DE LA RIBA 50 SANT CUGAT DEL VALLES BARCELONA 8174 934045400 ESPAÑA 78 NOVO NORDISK PHARMA VIA DE LOS POBLADOS 3 PARQUE EMPRESARIAL CRISTALIA - EDIFICIO 6 PLANTA 3ª MADRID MADRID 28033 913349800 ESPAÑA 84 EUROPHARMA, S.A. C PRAT DE LA RIBA 50 SANT CUGAT DEL VALLES BARCELONA 8174 934045400 ESPAÑA 85 TECEFARMA GUIFRE, 724. BADALONA BARCELONA 8918 ESPAÑA 89 CENTRUM C/ SAGITARIO 14 APDO CORREOS 5427, 03080 ALICANTE ALICANTE ALICANTE 3006 965288611 ESPAÑA 111 CINFA C/ OLAZ-CHIPI 10 POLIGONO INDUSTRIAL ARETA HUARTE-PAMPLONA NAVARRA 31620 902115882 ESPAÑA 112 PROCTER GAMBLE ESPAÑA AVDA BRUSELAS 24 ALCOBENDAS MADRID 28108 917222100 ESPAÑA 129 DISTA AVDA DE LA INDUSTRIA, 30 ALCOBENDAS MADRID 28108 902443300 ESPAÑA 133 BIAL-INDUSTRIAL FARMACEUTICA ALAMEDA URQUIJO 27 1º BILBAO BIZKAIA 48008 ESPAÑA 136 FARMALIDER ARAGONESES 15 ALCOBENDAS MADRID 28108 916612335 ESPAÑA 140 ESTEVE AV MARE DE DEU DE MONTSERRAT 221 BARCELONA BARCELONA 8041 ESPAÑA 145 ALLEN FARMACEUTICA C/ SEVERO OCHOA 2 P.T.M.
    [Show full text]
  • Biotech Innovation for Sustainability
    SUSTAINABILITY REPORT BIOTECH INNOVATION FOR SUSTAINABILITY 1 SUSTAINABILITY Throughout 2016, Bio Farma continued to innovate in order to improve the quality of life. For this reason, maintaining Gold rating in the annual PROPER assessment that is organized by the Indonesian Ministry of Environment and Forestry displayed a strong commitment made by Bio Farma to continue innovating for future sustainability. Organizing “Forum Riset Life Science Nasional (FRLN)” or National Life Science Research Forum, with “Challenges Toward National Research Independence in Life Science” as the theme in 2016 became another form of contribution given by Bio Farma within the biotechnology innovation industry to accelerate the down-streaming and commercialization of Life Science products, which have been acknowledged as national products and proud works of Indonesia’s best young talents. Domestically- produced Life Science products will push the availability of affordable biopharmaceutical products for all Indonesian people. Through biotechnological innovation, the Company contributes to Sustainable Development Goals (SGDs), which is by ensuring a healthy lifestyle and promoting the welfare of people at any age. We have a strong commitment to transparency and sustainable decision-making SUSTAINABILITY REPORT 2016 BIO FARMA ACCOMPLISHMENTS NOTES ON SUSTAINABLE ABOUT THIS REPORT JOURNEY OF SUSTAINABILITY TOWARDS BUSINESS BIO FARMA’S DEDICATION GOVERNANCE 2 SUSTAINABILITY TABLE OF CONTENTS 5 ACCOMPLISHMENTS TOWARDS SUSTAINABILITY 6 Economic Impact 58 Commitment
    [Show full text]
  • Products and Services Catalogue
    Products and Services Catalogue 1 Coverage of Content the Holding Welcome to the NWT 5 Company history 6 Energy production and saving 8 IT & Telco 26 Heating and cooling 9 Computer equipment supply 27 Electricity production 10 Data centre and cloud 28 Cheaper gas and electricity 11 IT management, safety and outsourcing 29 Service supervisory centre OZE 12 Information systems and applications 30 UNITED Call centre 31 Building industry 14 KINGDOM Project preparation 15 Holding 32 NWT International Ltd. ALPH passive houses 16 Internet stores 33 USA CYPRUS Panel production 18 Fillamentum strings for 3D printing 34 Fillamentum a.s. NWT Holding Ltd. Electrical installations 19 Park Tower 36 RR Technologies Trading Ltd. Enviel electric vehicles 38 Production greenhouses 20 Sheltered workshop 39 CZECH REPUBLIC Construction of turnkey production greenhouses 21 Backoffice and marketing 40 NWT a.s. Kameničany Farm 22 Farma Pod Hvězdou 41 EMEA s.r.o. SLOVAKIA Bezdínek Farm 23 Fillamentum Manufacturing Czech s.r.o. NWT Slovakia s.r.o. Agricultural sales organization 24 Branches 43 Farma Bezdínek s.r.o. NWT a.s., organizational unit Čerstvě utrženo, družstvo (coop) OVOZELA, družstvo (coop) Lorencova s.r.o. NWT Greenhouse s.r.o. (Farma Kameničany) Enviel Systems s.r.o. Bioplyn Bolešov s.r.o. (BGS Kameničany) 2 Coverage of the Holding Content 3 Welcome to the NWT For more than a quarter century, we have been among the most We invest in innovative projects and start-ups with a view toward important technology and innovation firms in the Czech Republic. on-going development and a sustainable environmental policy.
    [Show full text]
  • Marijuana Business Licenses Approved
    OREGON LIQUOR & CANNABIS COMMISSION Marijuana Business Licenses Approved as of 9/9/2021 Retail Medical LICENSE NUMBER LICENSEE NAME BUSINESS NAME LICENSE TYPE ACTIVE COUNTY Delivery Grade Hemp 050 100037147CC Hotbox Farms LLC Hotbox Farms Recreational Retailer Yes Baker Yes 050 10011127277 Scott, Inc 420VILLE Recreational Retailer Yes Baker 020 10017768FC7 Burnt River Farms, LLC Burnt River Farms LLC. Recreational Producer Yes Baker 030 10031846B25 Burnt River Farms, LLC Burnt River Farms LLC. Recreational Processor Yes Baker 060 1003692E356 Burnt River Farms, LLC Burnt River Farms LLC. Recreational Wholesaler Yes Baker 050 1003713A8A4 The Coughie Pot, LLC The Coughie Pot Recreational Retailer Yes Baker 050 10047883377 Sumpter Nugget, LLC Sumpter Nugget Recreational Retailer Yes Baker Yes 030 10071310CDB Nugget Candy Co, LLC Nugget Candy Co, LLC/Bad Rabbit Recreational Processor Yes Baker Yes Solventless 060 10079080A50 420BUNKERVILLE LLC 420 Bunkerville Recreational Wholesaler Yes Baker Yes 020 1007910A67C 420BUNKERVILLE LLC 420 Bunkerville Recreational Producer Yes Baker 020 1008998100D Burnt River Farms, LLC Burnt River Farms LLC Recreational Producer Yes Baker 060 1010135EC04 Hotbox Farms LLC Hotbox Farms Recreational Wholesaler Yes Baker 020 10104590FEE Bad Rabbit Farms LLC Bad Rabbit Farms LLC Recreational Producer Yes Baker 020 10001223B25 Fire Creek Farms LLC. Fire Creek Farms Recreational Producer Yes Benton 020 1000140D286 Bosmere Farms, Inc. Bosmere Farms, Inc. Recreational Producer Yes Benton 020 10004312ECD Grasshopper Farm,
    [Show full text]
  • Socio-Economic Transformation in Coal Transition Regions: Analysis and Proposed Approach Pilot Case in Upper Nitra, Slovakia
    Socio-economic transformation in coal transition regions: analysis and proposed approach Pilot case in Upper Nitra, Slovakia E. Donnari, S. Salanska, M. Matusiak, K.Rosina, C. Perpiña Castillo, R. Ribeiro Barranco, C. Jacobs-Crisioni, B. Kavalov, C. Lavalle, I. Maghiros, I. Seigneur, M. Boden, D. Pontikakis, H. Gerbelová, A. Spisto, S. Giaccaria, A. Purvins, L. Sereno, A.Bocin Dumitriu U. von Estorff, M. Masera 2018 This publication is a Science for Policy report by the Joint Research Centre (JRC), the European Commission’s science and knowledge service. It aims to provide evidence-based scientific support to the European policymaking process. The scientific output expressed does not imply a policy position of the European Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use that might be made of this publication. Contact information Name: Elena Donnari Address: European Commission, Joint Research Centre, 21 Rue Champs du Mars, 1049 Brussels, Belgium Email: [email protected] Tel.: +32-2-298 68 74 JRC Science Hub https://ec.europa.eu/jrc JRCxxxxx EUR xxxxx xx PDF ISBN xxx-xx-xx-xxxxx-x ISSN xxxx-xxxx doi:xx.xxxxx/xxxxxx Print ISBN xxx-xx-xx-xxxxx-x ISSN xxxx-xxxx doi:xx.xxxxx/xxxxxx Luxembourg: Publications Office of the European Union, 2018 © European Union, 2018 Reuse is authorised provided the source is acknowledged. The reuse policy of European Commission documents is regulated by Decision 2011/833/EU (OJ L 330, 14.12.2011, p. 39). For any use or reproduction of photos or other material that is not under the EU copyright, permission must be sought directly from the copyright holders.
    [Show full text]
  • ATA DE Julgamento Herrr,Rracão Pnrcão PRESENCIAL Srp 0612019 Fms
    r. .,:,1. , . #r,-$:{ {UrrL ..YIq-,BL:"!" ESTADO DE SERGIPE N,TTTXTCÍPTO ON JAPARATUBA sEToR DE LrcrrAÇÕEs E coNTRATos ATA DE JULGAMENTo Herrr,rracÃo pnrcÃo PRESENCIAL sRp 0612019 FMs As 1lhl5min (onze horas e quinze minutos) do dia 02/07/2019 (dois de julho de dois mil e dezenove), na sala da Comissão PermaÍrente de Licitação da Prefeitura Municipal de Japarahrba, sito na Praça Padre Caio Tavares, n. 86, Centro, reuniram-se o Pregoeiro e equipe de apoio, designados pelo Decreto n' 132/2018, de 13.08.2018, para abeÍura do envelope de Habilitação, relativos ao Processo Licitatório: 06/2019 FMS, Modalidade: Pregão Presencial, Tipo: Menor Preço, Objeto: í'Registro de preços parâ âquisição de MEDICAMENTOS que servirão para âtênder às necessidâdes do planejamento geral e ações de Secretâris de Saúde do Município de Japaratuba/SE, nos termos do Decreto Municipâl no 400t2014". Em face da não intenção de apresentar recurso poÍ parte dos licitantes, decide proceder ao jrígamento dos documentos relativos à habilitação das empresas: VIANA FARMA COMÉRCIO E REPRESENTAÇÕES LTDA - ME e da empresa C G FARMA DISTRIBIIIDORA EIRELI ME classificadas no respectivo ceÍame. Procedido à abertura do envelope contendo a documentação, após análise e conferência das mesmas, conforme o aft.43,I da Lei no 8.666/93, do edital de licitação. Foi disponibilizado para os licitantes presentes a documentação relativa a ti da referida em s4 conforme s abaixo: A documentação relativa para a HABILITAÇ O: VIÀNA FARMA CONdRCIO E REPRESENTAÇÕES LTDA-Mf, 01 Contrato Social OK 02
    [Show full text]
  • An Analytical Approach Applied to the Slovakian Coal Region †
    energies Article Regional Energy Transition: An Analytical Approach Applied to the Slovakian Coal Region † Hana Gerbelová *, Amanda Spisto and Sergio Giaccaria European Commission, Joint Research Centre (JRC), 1755 LE Petten, The Netherlands; [email protected] (A.S.); [email protected] (S.G.) * Correspondence: [email protected] † This paper is an extended version of our paper published in 15th Conference on Sustainable Development of Energy, Water and Environment Systems (SDEWES), Cologne, Germany, 1–5 September 2020. Abstract: This study presents an analytical framework supporting coal regions in a strategy toward the clean energy transition. The proposed approach uses a combination of value chain analysis and energy sector analysis that enables a comprehensive assessment considering local specificities. Its application to a case study of the Slovakian region Upper Nitra demonstrates practical examples of opportunities and challenges. The value chain analysis evaluates the coal mining industry, from coal extraction to electricity generation, in terms of jobs and business that are at risk by the closure of the coal mines. The complementary energy system analysis focuses on diversification of the energy mix, environmental impacts, and feasibility assessment of alternative energy technologies to the coal combusting sources. The results show a net positive cost benefit for all developed scenarios of replacing the local existing coal power plant. Although the installation of a new geothermal plant is estimated to be the most expensive option from our portfolio of scenarios, it presents the highest CO2 reduction in the electricity generation in Slovakia—34% less compare to the system employing the existing power plant.
    [Show full text]